Among the β4GalT family members, the clinical relevance of β4GalT4 was reported that the expression of β4GalT4 increases in colon cancer, and enhanced expression of β4GalT4 is associated with metastasis and poor prognosis of colon cancer [9]. Here, B4GALNT2 is linked to malignant colon neoplasm.